Nephro Care shares list at 90% premium on NSE SME platform

July 5, 2024

Nephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed by over 700 times. The company aims to establish a 100-bed multispeciality hospital in Kolkata using proceeds from the IPO. Nephro Care, led by Dr. Pratim Sengupta, focuses on comprehensive medical services for renal patients.

More To Explore

Offshore deals under I-T lens: Tiger Global vs government battle intensifies

In recent weeks, over a dozen foreign investors have received notices from India’s income tax department for allegedly skipping taxes on substantial transactions from 2018

April 7, 2025

China investors brace for ‘ugly’ Monday on US tariff retaliation

A gauge of Chinese stocks listed in the US plunged 8.9% on Friday, the most since October 2022, amid global market turmoil after Beijing announced

April 7, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003